Exome-wide association analysis reveals novel coding sequence variants associated with lipid traits in Chinese

Nature Communications

Volumn 6, Issue , 2015, Pages

  Tang, Clara S ^a   Zhang, He ^b   Cheung, Chloe Y Y ^a   Xu, Ming ^c   Ho, Jenny C Y ^a   Zhou, Wei ^b   Cherny, Stacey S ^a,d,e   Zhang, Yan ^f   Holmen, Oddgeir ^g,h   Au, Ka Wing ^a   Yu, Haiyi ^c   Xu, Lin ^a   Jia, Jia ^f   Porsch, Robert M ^a   Sun, Lijie ^c   Xu, Weixian ^c   Zheng, Huiping ^c   Wong, Lai Yung ^a   Mu, Yiming ⁱ   Dou, Jingtao ⁱ   Fong, Carol H Y ^a   Wang, Shuyu ^j   Hong, Xueyu ^a   Dong, Liguang ^k   Liao, Yanhua ^k   Wang, Jiansong ^k   Lam, Levina S M ^d   Su, Xi ^l   Yan, Hua ^l   Yang, Min Lee ^b   Chen, Jin ^b   Siu, Chung Wah ^a,d   Xie, Gaoqiang ^m   Woo, Yu Cho ^a   Wu, Yangfeng ⁿ   Tan, Kathryn C B ^a,d   Hveem, Kristian ^g   Cheung, Bernard M Y ^a,d,o   Zöllner, Sebastian ^p   Xu, Aimin ^a,d,o   Chen, Y Eugene ^b   Jiang, Chao Qiang ^q   Zhang, Youyi ^c   Lam, Tai Hing ^a   Ganesh, Santhi K ^b   Huo, Yong ^f   Sham, Pak C ^a,d,e   Lam, Karen S L ^a,d,o   Willer, Cristen J ^b   Tse, Hung Fat ^a,d   Gao, Wei ^c   more..

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^c PEKING UNIVERSITY THIRD HOSPITAL   (China)

^d UNIVERSITY OF HONG KONG   (Hong Kong)

^e UNIVERSITY OF HONG KONG   (Hong Kong)

^f PEKING UNIVERSITY FIRST HOSPITAL   (China)

^g NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

^h TRONDHEIM UNIVERSITY HOSPITAL   (Norway)

ⁱ CHINESE PLA GENERAL HOSPITAL   (China)

^j Beijing Hypertension League Institute   (China)

^k PEKING UNIVERSITY SHOUGANG HOSPITAL   (China)

^l WUHAN ASIA HEART HOSPITAL   (China)

^m PEKING UNIVERSITY   (China)

ⁿ PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

^o UNIVERSITY OF HONG KONG   (Hong Kong)

^p UNIVERSITY OF MICHIGAN   (United States)

^q Guangzhou No 12 Hospital   (China)

more..

Author keywords

[No Author keywords available]

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ANCESTRY; BIOLOGY; BLOOD; BLOOD SYSTEM DISORDER; CARDIOVASCULAR DISEASE; CYTOGENETICS; GENE EXPRESSION; GENETIC ANALYSIS; LIPID; POLYMORPHISM; RISK FACTOR;

ARTICLE; BODY MASS; CHINESE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CORONARY RISK; EXOME; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC TRAIT; GENETIC VARIABILITY; GENOTYPE; HUMAN; LIPID BLOOD LEVEL; META ANALYSIS; PERSONALIZED MEDICINE; PROTEIN ANALYSIS; SEQUENCE ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM; TRIACYLGLYCEROL BLOOD LEVEL; ASIAN CONTINENTAL ANCESTRY GROUP; GENETIC VARIATION; GENETICS; LIPID METABOLISM; METABOLISM;

CHINA;

ASIAN CONTINENTAL ANCESTRY GROUP; CHOLESTEROL, HDL; CHOLESTEROL, LDL; EXOME; GENETIC VARIATION; GENOTYPE; HUMANS; LIPID METABOLISM; TRIGLYCERIDES;

EID: 84951334880     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/ncomms10206     Document Type: Article

References (57)

1. Do, R. et al. Common variants associated with plasma triglycerides and risk for coronary artery disease. Nat. Genet. 45, 1345-1352 (2013).
2. Mendis, S., Puska, P. & Norrving, B. Global Atlas on Cardiovascular Disease Prevention and Control, VI. pp 155 (World Health Organization in collaboration with the World Heart Federation and the World Stroke Organization, 2011).
3. Wong, N. D. Epidemiological studies of CHD and the evolution of preventive cardiology. Nat. Rev. Cardiol. 11, 276-289 (2014).
4. Global Lipids Genetics, C et al. Discovery and refinement of loci associated with lipid levels. Nat. Genet. 45, 1274-1283 (2013).
5. Cohen, J. C., Boerwinkle, E., Mosley, Jr T. H. & Hobbs, H. H. Sequence variations in PCSK9, low LDL, and protection against coronary heart disease. New Engl. J. Med. 354, 1264-1272 (2006).
6. Lange, L. A. et al. Whole-exome sequencing identifies rare and low-frequency coding variants associated with LDL cholesterol. Am. J. Hum. Genet. 94, 233-245 (2014).
7. Brown, M. S. & Goldstein, J. L. A receptor-mediated pathway for cholesterol homeostasis. Science 232, 34-47 (1986).
8. Crosby, J. et al. Loss-of-function mutations in APOC3, triglycerides, and coronary disease. New Engl. J. Med. 371, 22-31 (2014).
9. Jorgensen, A. B., Frikke-Schmidt, R., Nordestgaard, B. G. & Tybjaerg-Hansen, A. Loss-of-function mutations in APOC3 and risk of ischemic vascular disease. New Engl. J. Med. 371, 32-41 (2014).
10. Peloso, G. M. et al. Association of low-frequency and rare coding-sequence variants with blood lipids and coronary heart disease in 56,000 whites and blacks. Am. J. Hum. Genet. 94, 223-232 (2014).
11. Teslovich, T. M. et al. Biological, clinical and population relevance of 95 loci for blood lipids. Nature 466, 707-713 (2010).
12. 1000 Genomes Project Consortium et al. An integrated map of genetic variation from 1,092 human genomes. Nature 491, 56-65 (2012).
13. Scheinfeldt, L. B. & Tishkoff, S. A. Recent human adaptation: genomic approaches, interpretation and insights. Nat. Rev. Genet. 14, 692-702 (2013).
14. Tachmazidou, I. et al. A rare functional cardioprotective APOC3 variant has risen in frequency in distinct population isolates. Nat. Commun. 4, 2872 (2013).
15. Pollin, T. I. et al. A null mutation in human APOC3 confers a favorable plasma lipid profile and apparent cardioprotection. Science 322, 1702-1705 (2008).
16. Rosenberg, N. A. et al. Genome-wide association studies in diverse populations. Nat. Rev. Genet. 11, 356-366 (2010).
17. Zhang, Y. et al. Rare coding variants and breast cancer risk: evaluation of susceptibility Loci identified in genome-wide association studies. Cancer Epidemiol. Biomarkers Prev. 23, 622-628 (2014).
18. Holmen, O. L. et al. Systematic evaluation of coding variation identifies a candidate causal variant in TM6SF2 influencing total cholesterol and myocardial infarction risk. Nat. Genet. 46, 345-351 (2014).
19. Kozlitina, J. et al. Exome-wide association study identifies a TM6SF2 variant that confers susceptibility to nonalcoholic fatty liver disease. Nat. Genet. 46, 352-356 (2014).
20. Anstee, Q. M. & Day, C. P. The genetics of NAFLD. Nat. Rev. Gastroenterol. Hepatol. 10, 645-655 (2013).
21. CARDIoGRAMplusC4D Consortium et al. Large-scale association analysis identifies new risk loci for coronary artery disease. Nat. Genet. 45, 25-33 (2013).
22. Liu, D. J. et al. Meta-analysis of gene-level tests for rare variant association. Nat. Genet. 46, 200-204 (2014).
23. Li, M. X., Gui, H. S., Kwan, J. S., Bao, S. Y. & Sham, P. C. A comprehensive framework for prioritizing variants in exome sequencing studies of Mendelian diseases. Nucleic Acids Res. 40, e53 (2012).
24. Li, B. & Leal, S. M. Methods for detecting associations with rare variants for common diseases: application to analysis of sequence data. Am. J. Hum. Genet. 83, 311-321 (2008).
25. Wu, M. C. et al. Rare-variant association testing for sequencing data with the sequence kernel association test. Am. J. Hum. Genet. 89, 82-93 (2011).
26. Price, A. L. et al. Pooled association tests for rare variants in exon-resequencing studies. Am. J. Hum. Genet. 86, 832-838 (2010).
27. Romeo, S. et al. Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease. Nat. Genet. 40, 1461-1465 (2008).
28. Speliotes, E. K. et al. Genome-wide association analysis identifies variants associated with nonalcoholic fatty liver disease that have distinct effects on metabolic traits. PLoS Genet. 7, e1001324 (2011).
29. Sookoian, S. & Pirola, C. J. Meta-analysis of the influence of I148M variant of patatin-like phospholipase domain containing 3 gene (PNPLA3) on the susceptibility and histological severity of nonalcoholic fatty liver disease. Hepatology 53, 1883-1894 (2011).
30. Anstee, Q. M., Targher, G. & Day, C. P. Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis. Nat. Rev. Gastroenterol. Hepatol. 10, 330-344 (2013).
31. He, S. et al. A sequence variation (I148M) in PNPLA3 associated with nonalcoholic fatty liver disease disrupts triglyceride hydrolysis. J. Biol. Chem. 285, 6706-6715 (2010).
32. Pirazzi, C. et al. Patatin-like phospholipase domain-containing 3 (PNPLA3) I148M (rs738409) affects hepatic VLDL secretion in humans and in vitro. J. Hepatol. 57, 1276-1282 (2012).
33. Smagris, E. et al.Pnpla3I148M knockin mice accumulate PNPLA3 on lipid droplets and develop hepatic steatosis. Hepatology 61, 108-118 (2014).
34. Speliotes, E. K. et al. PNPLA3 variants specifically confer increased risk for histologic nonalcoholic fatty liver disease but not metabolic disease. Hepatology 52, 904-912 (2010).
35. Palmer, C. N. et al. Paradoxical lower serum triglyceride levels and higher type 2 diabetes mellitus susceptibility in obese individuals with the PNPLA3 148M variant. PLoS ONE 7, e39362 (2012).
36. Huang, Y. et al. A feed-forward loop amplifies nutritional regulation of PNPLA3. Proc. Natl Acad. Sci. USA 107, 7892-7897 (2010).
37. Smagris, E. et al. Pnpla3I148M knockin mice accumulate PNPLA3 on lipid droplets and develop hepatic steatosis. Hepatology 61, 108-118 (2015).
38. Lake, A. C. et al. Expression, regulation, and triglyceride hydrolase activity of Adiponutrin family members. J. Lipid Res. 46, 2477-2487 (2005).
39. Ishimaru, Y. et al. Transient receptor potential family members PKD1L3 and PKD2L1 form a candidate sour taste receptor. Proc. Natl Acad. Sci. USA 103, 12569-12574 (2006).
40. ENCODE Project Consortium et al. An integrated encyclopedia of DNA elements in the human genome. Nature 489, 57-74 (2012).
41. Manning, A. K. et al. A genome-wide approach accounting for body mass index identifies genetic variants influencing fasting glycemic traits and insulin resistance. Nat. Genet. 44, 659-669 (2012).
42. Scott, R. A. et al. Large-scale association analyses identify new loci influencing glycemic traits and provide insight into the underlying biological pathways. Nat. Genet. 44, 991-1005 (2012).
43. Dupuis, J. et al. New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk. Nat. Genet. 42, 105-116 (2010).
44. Wang, H., Gauthier, B. R., Hagenfeldt-Johansson, K. A., Iezzi, M. & Wollheim, C. B. Foxa2 (HNF3beta ) controls multiple genes implicated in metabolism-secretion coupling of glucose-induced insulin release. J. Biol. Chem. 277, 17564-17570 (2002).
45. Li, A., Tian, X., Sung, S. W. & Somlo, S. Identification of two novel polycystic kidney disease-1-like genes in human and mouse genomes. Genomics 81, 596-608 (2003).
46. Joshi-Tope, G. et al. Reactome: a knowledgebase of biological pathways. Nucleic Acids Res. 33, D428-D432 (2005).
47. Sugimoto, H., Banchio, C. & Vance, D. E. Transcriptional regulation of phosphatidylcholine biosynthesis. Prog. Lipid Res. 47, 204-220 (2008).
48. Fournier, N. et al. HDL phospholipid content and composition as a major factor determining cholesterol efflux capacity from Fu5AH cells to human serum. Arterioscler. Thromb. Vasc. Biol. 17, 2685-2691 (1997).
49. Wu, Y. et al. Trans-ethnic fine-mapping of lipid loci identifies populationspecific signals and allelic heterogeneity that increases the trait variance explained. PLoS Genet. 9, e1003379 (2013).
50. Chen, C. et al. High plasma level of fibroblast growth factor 21 is an Independent predictor of type 2 diabetes: a 5.4-year populationbased prospective study in Chinese subjects. Diabetes Care 34, 2113-2115 (2011).
51. Hui, E. et al. Elevated circulating pigment epithelium-derived factor predicts the progression of diabetic nephropathy in patients with type 2 diabetes. J. Clin. Endocrinol. Metab. 99, E2169-E2177 (2014).
52. Friedewald, W. T., Levy, R. I. & Fredrickson, D. S. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin. Chem. 18, 499-502 (1972).
53. Eagle, K. A. et al. ACC/AHA 2004 guideline update for coronary artery bypass graft surgery: summary article. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1999 Guidelines for Coronary Artery Bypass Graft Surgery). J. Am. Coll Cardiol. 44, e213-310 (2004).
54. Grove, M. L. et al. Best practices and joint calling of the HumanExome BeadChip: the CHARGE Consortium. PLoS ONE 8, e68095 (2013).
55. Guo, Y. et al. Illumina human exome genotyping array clustering and quality control. Nat. Protoc. 9, 2643-2662 (2014).
56. Nyholt, D. R. A simple correction for multiple testing for single-nucleotide polymorphisms in linkage disequilibrium with each other. Am. J. Hum. Genet. 74, 765-769 (2004).
57. Li, M. X., Yeung, J. M., Cherny, S. S. & Sham, P. C. Evaluating the effective numbers of independent tests and significant p-value thresholds in commercial genotyping arrays and public imputation reference data sets. Hum. Genet. 131, 747-756 (2012).